Charles River Laboratories
Logotype for Charles River Laboratories International Inc

Charles River Laboratories (CRL) investor relations material

Charles River Laboratories Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Charles River Laboratories International Inc
Q4 2025 earnings summary18 Feb, 2026

Executive summary

  • 2025 results reached the upper end of revenue and non-GAAP EPS guidance, with stabilization in biopharma demand and strategic progress in portfolio and innovation initiatives.

  • CEO Jim Foster announced retirement, with Birgit Girshick named as successor, and new CFO and CLO appointments to strengthen leadership.

  • Fourth-quarter revenue was $994.2 million, down 0.8% year-over-year; full-year revenue was $4.02 billion, down 0.9% year-over-year.

  • Non-cash impairments and goodwill charges significantly impacted GAAP results, especially in Biologics Solutions and Cell Solutions.

  • Management highlighted improved DSA net bookings in Q4 and ongoing strategic initiatives for future growth.

Financial highlights

  • FY 2025 revenue was $4,015.4M, down 0.9% year-over-year; organic revenue declined 1.6%.

  • 4Q25 revenue was $994.2M, down 0.8% year-over-year; organic revenue declined 2.6%.

  • FY 2025 non-GAAP operating margin was 19.8%, down 10 bps; 4Q25 non-GAAP operating margin was 18.1%, down 180 bps.

  • FY 2025 non-GAAP EPS was $10.28, nearly flat year-over-year; 4Q25 non-GAAP EPS was $2.66, down 10.2%.

  • Free cash flow for 2025 was $518.5M; 2026 guidance is $375–$400M.

Outlook and guidance

  • 2026 reported revenue growth expected to be at least flat to +1.5%; organic revenue growth expected between (1.0)% and flat.

  • 2026 non-GAAP EPS guidance is $10.70–$11.20, representing 4–9% year-over-year growth, driven by cost savings, acquisitions, and a lower tax rate.

  • Non-GAAP operating margin expected to improve by 20–50 bps, driven by the K.F. acquisition.

  • 1Q26 non-GAAP EPS expected to decline high-teens year-over-year due to timing of NHP shipments, CEO transition costs, and higher DSA costs.

  • Guidance does not include the impact of planned divestitures representing about 7% of 2025 revenue.

Impact of Biologics/Cell Solutions impairments?
DSA Q4 revenue vs. booking trends reconciliation
Rationale for 7% revenue divestitures in 2026?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Charles River Laboratories earnings date

Logotype for Charles River Laboratories International Inc
Q1 20266 May, 2026
Charles River Laboratories
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Charles River Laboratories earnings date

Logotype for Charles River Laboratories International Inc
Q1 20266 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Charles River Laboratories International, Inc. is a concract research organization providing drug discovery, non-clinical development and safety testing services in the United States, Europe, Canada and the Asia Pacific regions. The Company provides research models and related services to support clients from target identification through non-clinical development. The Company operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Support.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage